文献速递骨肌MR

脊柱关节炎骶髂关节磁共振成像:使用或不使用静脉对比剂?初步报告

Magnetic resonance imaging of the sacroiliac joints in SpA: with or without intravenous contrast media? A preliminary report.
PubMed 文献 · Radiol Med · 2019-03-13

本研究纳入43例临床诊断脊柱关节炎且增强MRI显示活动性骶髂关节炎的患者,计划在TNF拮抗剂治疗6个月后复查MRI,最终38例纳入分析,其中36例临床评估改善。增强MRI序列评分改善均值3.18(范围0-12),平扫序列为1.63(范围0-7),两组改善均具统计学显著性,且组间差异显著。增强MRI与BASDAI的一致性(K=0.53,一致率92.11%)优于平扫MRI(K=0.11,一致率57.89%)。作者认为增强评估是评估脊柱关节炎骶髂关节治疗反应可靠的工具,优于骨髓水肿评估,因此建议在此类患者MRI中采用。

要点

  • 增强MRI序列评分改善均值3.18(范围0-12),平扫序列为1.63(范围0-7),增强组改善幅度更大且组间差异显著(P=8.598e-07)。
  • 增强MRI与BASDAI一致性K=0.53(一致率92.11%,P=0.0001),优于平扫MRI的K=0.11(一致率57.89%,P=0.06)。
  • 作者认为增强评估是评估脊柱关节炎骶髂关节治疗反应可靠的工具,优于骨髓水肿评估,建议在此类患者MRI中采用。

核心结论

  • 增强评估是评估脊柱关节炎骶髂关节治疗反应可靠的工具,优于骨髓水肿评估,因此建议在此类患者MRI中采用。

研究设计与样本

  • 初步报告,43例临床诊断脊柱关节炎且增强MRI显示活动性骶髂关节炎的患者(25女18男,平均年龄54±16.60岁,范围22-75岁)计划在TNF拮抗剂治疗6个月后复查MRI,最终38例纳入分析;采用描述性统计、Student t检验和Cohen kappa分析,P<0.05为统计学显著。

关键影像表现/征象

  • MRI评估骨髓水肿(BMO)范围和病理强化(骨炎/滑膜炎)。
  • 增强MRI序列评分改善均值3.18(范围0-12),平扫序列改善均值1.63(范围0-7)。
  • 增强MRI与BASDAI一致性K=0.53(一致率92.11%,P=0.0001),平扫MRI与BASDAI一致性K=0.11(一致率57.89%,P=0.06)。

诊断标准与关键数值

  • 增强MRI序列治疗前后评分差值(改善)均值3.18(范围0-12),组内统计学显著(P=7.097e-08)。
  • 平扫MRI序列治疗前后评分差值(改善)均值1.63(范围0-7),组内统计学显著(P=6.741e-06)。
  • 增强与平扫两组评分改善差异显著(P=8.598e-07)。
  • 增强MRI与BASDAI一致性K=0.53(一致率92.11%,P=0.0001);平扫MRI与BASDAI一致性K=0.11(一致率57.89%,P=0.06)。

临床应用与阅片要点

  • 作者认为增强评估是评估脊柱关节炎骶髂关节治疗反应可靠的工具,优于骨髓水肿评估,建议在此类患者MRI中采用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECT: Active sacroiliitis based on magnetic resonance imaging (MRI) without intravenous (I.V.) contrast material injection is considered sufficient for the diagnosis of spondyloarthritis (SpA), according to the Assessment of SpondyloArthritis International Society (ASAS) criteria. This work shows the added value of administering I.V. contrast material when evaluating the response to tumor necrosis factor (TNF) antagonists therapy, on the extension of bone marrow oedema (BMO) and pathological enhancement (osteitis/synovitis) in the sacroiliac joints (SIJs) on MRI.

MATERIALS AND METHODS: Forty-three patients (25 females and 18 males, mean age of 54 ± 16.60 years, range 22-75 years) with a clinical diagnosis of SpA and active sacroiliitis at MRI with I.V. contrast material, were considered for a follow-up MRI after 6 months of TNF antagonists therapy. Disease activity was monitored by a Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) questionnaire. Descriptive statistics, Student's t test and Cohen's kappa were used. P < 0.05 was considered statistically significant.

RESULTS: Thirty-eight patients were finally included in the study; 36 of them showed an improvement on clinical assessment after therapy. Score's difference (improvement) after treatment was calculated in the MRI sequences both with and without contrast agent (respectively, mean value and range 3.18, 0-12 with contrast and 1.63, 0-7 without contrast). This improvement was statistically significant in each group (P value of 7.097e-08 with contrast and 6.741e-06 without contrast), and there was a significant difference between the two group too (P-value of 8.598e-07). Cohen's kappa for dichotomous variables showed a better agreement between the post-contrast MRI findings and BASDAI (K = 0.53, agreement = 92.11%, P = 0.0001) than MRI without contrast and BASDAI (K = 0.11, agreement = 57.89%, P = 0.06).

CONCLUSIONS: The evaluation of enhancement is a reliable tool for the assessment of the response to therapy in SIJs involvement in SpA, better than BMO; hence, it should be advised in the MRI of these patients.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Gentili F, Cantarini L, Fabbroni M, et al. Magnetic resonance imaging of the sacroiliac joints in SpA: with or without intravenous contrast media? A preliminary report. Radiol Med. 2019. PMID: 30868439. doi:10.1007/s11547-019-01016-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。